Denali Therapeutics Inc (DNLI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.90B
Last updated: Nov 17, 2026 at 4:20 PM ET
Denali Therapeutics Inc (DNLI) Stock Chart
Denali Therapeutics (DNLI) has a latest price of $18.00 on Nov 17, 2026, 34.1% below its 52-week high of $27.30. Its price rose 3.2% over the past 12 months. The month-end price rose 21.1% since Dec 2017, a compound annual rate of 2.2%.
Price Chart
From Dec 2017 to Oct 2026, its highest month-end close was $83.76 in Dec 2020 and its lowest $12.59 in Jul 2018, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart DNLI with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for DNLI.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 29.9%, and over 6 months it fell 0.6%. The month-end price rose 0.6% over the 3 years through Oct 2026, a compound annual rate of 0.2%.
| Period | Change |
|---|---|
| 1 month | -0.2% |
| 3 months | -29.9% |
| 6 months | -0.6% |
| 12 months | +3.2% |
| 12 months, with dividends | +3.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +0.6% | +0.2% |
| 5 years | -60.8% | -17.1% |
| Since Dec 2017 | +21.1% | +2.2% |
Price by Year
Its best calendar year was 2020, when the price rose 380.8%, and its weakest was 2021, when it fell 46.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $18.94 | +14.7% |
| 2025 | $16.51 | -19.0% |
| 2024 | $20.38 | -5.0% |
| 2023 | $21.46 | -22.8% |
| 2022 | $27.81 | -37.6% |
| 2021 | $44.60 | -46.8% |
| 2020 | $83.76 | +380.8% |
| 2019 | $17.42 | -15.7% |
| 2018 | $20.66 | +32.1% |
Trading Range
The price is 8.2% below its 50-day average of $19.61 and 15.0% below its 200-day average of $21.18.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $18.00 | |
| 52-week high | $27.30 | -34.1% |
| 52-week low | $15.34 | +17.3% |
| 50-day average | $19.61 | -8.2% |
| 200-day average | $21.18 | -15.0% |
Price Risk
Over 3 years, its largest fall from a peak was 63.7%.
| Measure | Value |
|---|---|
| 1-year beta | 1.51 |
| Largest fall, 1 year | -35.3% |
| Largest fall, 3 years | -63.7% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About DNLI
What is DNLI's 1-year price change?
Denali Therapeutics's price rose 3.2% over the past 12 months. With dividends included, the 12-month total return was 3.2%.
What is DNLI's 5-year price change?
Denali Therapeutics's month-end price fell 60.8% over the 5 years through Oct 2026, a compound annual decline of 17.1%. These figures leave out dividends.
What is DNLI's 52-week high and low?
Denali Therapeutics's 52-week high is $27.30 and its 52-week low is $15.34. Its latest price of $18.00 on Nov 17, 2026 is 34.1% below the high.
What is DNLI's beta?
Denali Therapeutics's 1-year beta against the S&P 500 is 1.51, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 35.3%.
Is the DNLI chart free?
Yes. Advanced Charting for DNLI is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
DNLI pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors